Cited by 804Neuroendocrine regulation and behaviorNeuropeptides and Animal PhysiologyMemory and Neural Mechanisms

Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala

Huber, Daniel, Veinante, Pierre, Stoop, Ron·2005·Science

Abstract

Vasopressin and oxytocin strongly modulate autonomic fear responses, through mechanisms that are still unclear. We describe how these neuropeptides excite distinct neuronal populations in the central amygdala, which provides the major output of the amygdaloid complex to the autonomic nervous system. We identified these two neuronal populations as part of an inhibitory network, through which vasopressin and oxytocin modulate the integration of excitatory information from the basolateral amygdala and cerebral cortex in opposite manners. Through this network, the expression and endogenous activation of vasopressin and oxytocin receptors may regulate the autonomic expression of fear.

Integrity signals

Registry

Crossref · 10.1126/science.1105636

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the central amygdala, the medial part relates to fear and the lateral part to anxiety, and only the lateral part has abundant oxytocin receptors.

    “The medial CeA (mCeA) and lateral CeA (lCeA) are involved in fear and anxiety,5 respectively, but only the lCeA is rich in OT receptors.6”

    From Oxytocin increases anxiety to unpredictable threat (2013) · cites this paper as [6]

  • Within the rodent central amygdala, oxytocin receptor density differs across subdivisions.

    “OT receptor density varies by subdivision within the central nucleus of the rodent amygdala (CeA)4,6”

    From Oxytocin increases anxiety to unpredictable threat (2013) · cites this paper as [6]

  • OT is a neuromodulator with both excitatory and inhibitory effects in neurons of the central amygdala, suggesting that the behavioral effect of OT can go both ways.

    “the finding that, at the cellular level, OT is a neuromodulator with both excitatory and inhibitory effects in neurons of the central amygdala (Huber et al., 2005) suggests that the behavioral effect of OT can go both ways.”
  • OXT can inhibit neurons in the centromedial amygdala through excitatory effects on GABAergic projections from the lateral and capsular central nucleus, disrupting integration of information and inhibiting amygdala output to fear-responding areas.

    “Although the mechanisms of these effects are unclear, it has been shown that OXT can inhibit neurons in the centromedial amygdala through its excitatory effects on g-aminobutyric acid (GABA) inhibitory (GABAergic) projections that originate from the lateral and capsular part of the central nucleus of the amygdala, which disrupts integration of information and inhibits amygdala output to areas of”
  • OXT promotes GABAergic inhibition in the amygdala, making the amygdala a good candidate target for OXT's effects.

    “The amygdala is a good candidate target for OXT's effects given that, like other anxiolytic pharmacotherapies, OXT promotes GABAergic inhibition in the amygdala (Huber et al, 2005).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Huber, D., Veinante, P., & Stoop, R.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Stoop, Ron
Venue
Science
Published
2005-04-08
Volume
308
Issue
5719
Pages
245-248
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W1998872047
Cited by
804
References
28
Citations by year
2026: 15 · 2025: 19 · 2024: 25 · 2023: 18 · 2022: 32 · 2021: 43 · 2020: 56 · 2019: 30 · 2018: 47 · 2017: 50 · 2016: 38 · 2015: 60 · 2014: 45 · 2013: 47 · 2012: 52
FWCI
44.61
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Keywords
vasopressin, oxytocin, central amygdala, neuropeptide receptors, basolateral amygdala, cerebral cortex, fear expression
MeSH terms
Amygdala, Animals, Autoradiography, Fear, gamma-Aminobutyric Acid, Neurons, Oxytocin, Tetrodotoxin, Vasopressins, Rats, Sprague-Dawley, Receptors, Vasopressin, Receptors, Oxytocin, Patch-Clamp Techniques, Rats, Antidiuretic Hormone Receptor Antagonists, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review